EEF2K and neoplasm: In line with this, it is proven that elongation factor 2 kinase (EF2K) is overexpressed in breast cancer of patients with mutations in BRCA1 (a human tumor suppressor gene), consequently triggering significant tumor growth and poor survival rate.